# Alignment Healthcare

Type: Company (ALHC)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/alignment-healthcare
Canonical HTML page: https://gethealthbrief.com/entity/alignment-healthcare

## Timeline

- **2026-03-14**: Insider Selling — President and another insider report share sales in regulatory filings.
- **2026-03-10**: Analyst Downgrade — Wall Street Zen cuts ALHC rating to Hold.
- **2026-03-03**: Offering Priced — Secondary offering is priced at $19.46 per share.
- **2026-03-02**: Secondary Offering Announced — Company announces intent to sell 13.2 million shares to raise capital.
- **2026-03-01**: Expected Q4 Earnings Call — Management is anticipated to provide final 2025 figures and formal guidance for the 2026 fiscal year.
- **2026-02-28**: Q4 Earnings Report — Alignment Healthcare reports a declining net loss for the fourth quarter of 2025.
- **2026-02-25**: Earnings Preview Release — FinancialContent and other market trackers highlight ALHC as a key stock to watch ahead of Q4 reporting.
- **2026-02-18**: Baird Model Update — Analysts at Baird set a bullish $59 price target for ALHC, signaling high confidence in the tech-enabled MA model.

## Recent coverage (3 stories)

### Alignment Healthcare Insiders Sell Shares Following $250M Secondary Offering
2026-03-14 03:08:58 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Alignment Healthcare (NASDAQ: ALHC) has reported significant insider selling, including a 29,113-share disposal by its President, shortly after a major secondary offering. These transactions occur as the company navigates a shift in analyst sentiment and a challenging regulatory environment for Medicare Advantage providers.
Full story: https://gethealthbrief.com/story/alignment-healthcare-insider-selling-analysis

### Alignment Healthcare Downgraded to Hold Amid Medicare Advantage Headwinds
2026-03-10 08:16:35 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Wall Street Zen has lowered its rating on Alignment Healthcare (ALHC) to "Hold," reflecting broader caution within the Medicare Advantage sector. The downgrade comes as specialized insurers face tightening margins and regulatory shifts in the federal reimbursement landscape.
Full story: https://gethealthbrief.com/story/alignment-healthcare-downgraded-hold-wall-street-zen

### Alignment Healthcare Q4 Preview: Tech-Enabled Medicare Advantage in Focus
2026-02-25 05:04:46 · Sentiment: Neutral · Impact: 5/10 · Sources: 8

Alignment Healthcare (ALHC) is set to report its fourth-quarter results, with investors focusing on membership growth and the medical loss ratio (MLR) within its tech-enabled Medicare Advantage platform. As the MA market faces regulatory headwinds, ALHC's ability to maintain clinical outcomes through its proprietary AVA software remains a critical differentiator.
Full story: https://gethealthbrief.com/story/alignment-healthcare-q4-earnings-preview-medicare-advantage

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.